Table 2.
Ligand | Targeted drug delivery | Reference | |
---|---|---|---|
Advantages | Disadvantages | ||
Antibody | - Barely affected by nucleases in vivo - Different antibodies to bind to the same antigen which has multiple epitopes - High affinity to the target |
- High immunogenicity - Easily loss of activity - Susceptible to high temperature and pH changes - Animal-based production |
[73] |
Aptamer | - Chemical synthesis - Smaller than antibodies (about ten times) - Low immunogenicity - Easy modification |
- Susceptible to excess nucleases in a biological system - Low affinity compared to antibody - Limited diversity of possible secondary and tertiary structures |
[74] |
Peptide | - Peptide libraries for almost any desired target - Extremely high receptor affinity - Only around 10 amino acids - High stability |
- More expensive and time-consuming - Limited production of peptides with a predetermined length - More potentially active sequences could be missed |
[75] |